Optimal mode for delivery of seasonal malaria chemoprevention in Ouelessebougou, Mali: A cluster randomized trial.

Optimal mode for delivery of seasonal malaria chemoprevention in Ouelessebougou, Mali: A cluster randomized trial.

Seasonal malaria chemoprevention (SMC), the administration of complete therapeutic courses of antimalarials to children aged 3-59 months during the malaria transmission season, is a new strategy recommended by the World Health Organization (WHO) for malaria control in Sahelian countries such as Mali...

Full description

Bibliographic Details
Main Authors:	Amadou Barry, Djibrilla Issiaka, Tiangoua Traore, Almahamoudou Mahamar, Boubacar Diarra, Issaka Sagara, Diakalia Kone, Ogobara K Doumbo, Patrick Duffy, Michal Fried, Alassane Dicko
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2018-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC5837084?pdf=render

Similar Items

Adverse pregnancy outcomes among women presenting at antenatal clinics in Ouélessébougou, Mali
by: Naissem Andemel, et al.
Published: (2020-03-01)

Effect of three years’ seasonal malaria chemoprevention on molecular markers of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine and amodiaquine in Ouelessebougou, Mali
by: Almahamoudou Mahamar, et al.
Published: (2022-02-01)

Effect of 4 years of seasonal malaria chemoprevention on the acquisition of antibodies to Plasmodium falciparum antigens in Ouelessebougou, Mali
by: Almahamoudou Mahamar, et al.
Published: (2021-01-01)

Measuring the impact of seasonal malaria chemoprevention as part of routine malaria control in Kita, Mali
by: Fatou Diawara, et al.
Published: (2017-08-01)

Seasonal Malaria Chemoprevention with Sulphadoxine-Pyrimethamine and Amodiaquine Selects Pfdhfr-dhps Quintuple Mutant Genotype in Mali.
by: Hamma Maiga, et al.
Published: (2016-01-01)

Seasonal malaria vaccination: protocol of a phase 3 trial of seasonal vaccination with the RTS,S/AS01E vaccine, seasonal malaria chemoprevention and the combination of vaccination and chemoprevention
by: Ismaila Thera, et al.
Published: (2020-09-01)

Genome-wide genetic variation and molecular surveillance of drug resistance in Plasmodium falciparum isolates from asymptomatic individuals in Ouélessébougou, Mali
by: Leen N. Vanheer, et al.
Published: (2023-06-01)

A novel locus in CSMD1 gene is associated with increased susceptibility to severe malaria in Malian children
by: Delesa Damena, et al.
Published: (2024-05-01)

Monitoring of the Sensitivity In Vivo of <i>Plasmodium falciparum</i> to Artemether-Lumefantrine in Mali
by: Modibo Diarra, et al.
Published: (2021-01-01)

Acquisition of antibodies that block Plasmodium falciparum adhesion to placental receptor chondroitin sulfate A with increasing gravidity in Malian women
by: Almahamoudou Mahamar, et al.
Published: (2024-01-01)

School-aged children based seasonal malaria chemoprevention using artesunate-amodiaquine in Mali
by: Mahamadou A. Thera, et al.
Published: (2018-05-01)

Impact of intermittent preventive treatment with sulphadoxine-pyrimethamine targeting the transmission season on the incidence of clinical malaria in children in Mali
by: Toure Ousmane B, et al.
Published: (2008-07-01)

Pregnancy outcomes in a malaria-exposed Malian cohort of women of child-bearing age
by: Santara Gaoussou, et al.
Published: (2022-12-01)

Age-dependent increase in antibodies that inhibit Plasmodium falciparum adhesion to a subset of endothelial receptors
by: Oumar Attaher, et al.
Published: (2019-04-01)

Molecular markers of resistance to sulphadoxine-pyrimethamine one year after implementation of intermittent preventive treatment of malaria in infants in Mali
by: Coulibaly Oumar M, et al.
Published: (2010-01-01)

Recent malaria does not substantially impact COVID-19 antibody response or rates of symptomatic illness in communities with high malaria and COVID-19 transmission in Mali, West Africa
by: John Woodford, et al.
Published: (2022-08-01)

Antibody Levels to Plasmodium falciparum Erythrocyte Membrane Protein 1-DBLγ11 and DBLδ-1 Predict Reduction in Parasite Density
by: Brittany N. Araj, et al.
Published: (2021-06-01)

The duration of protection against clinical malaria provided by the combination of seasonal RTS,S/AS01E vaccination and seasonal malaria chemoprevention versus either intervention given alone
by: Matthew Cairns, et al.
Published: (2022-10-01)

Space-time clustering of childhood malaria at the household level: a dynamic cohort in a Mali village
by: Ouattara Amed, et al.
Published: (2006-11-01)

Higher platelet counts and platelet factors are associated with a reduction in Plasmodium falciparum parasite density in young Malian children
by: Oumar Attaher, et al.
Published: (2024-02-01)

The implementation of malaria intermittent preventive trialtreatment with sulphadoxine-pyrimethamine in infants reduced all-cause mortality in the district of Kolokani, Mali: results from a cluster randomized control
by: Dicko Alassane, et al.
Published: (2012-03-01)

Variation in Relative Abundance of Small Mammal Species Caught in Two Different Ecosystems and Implicated in the Spread of Emerging Pathogens in Mali
by: Abdoulaye Kassoum Koné, et al.
Published: (2024-10-01)

Increase in EPI vaccines coverage after implementation of intermittent preventive treatment of malaria in infant with Sulfadoxine -pyrimethamine in the district of Kolokani, Mali: Results from a cluster randomized control trial
by: Salomon Roger, et al.
Published: (2011-07-01)

Factors Influencing Second and Third Dose Observance during Seasonal Malaria Chemoprevention (SMC): A Quantitative Study in Burkina Faso, Mali and Niger
by: Anyirékun Fabrice Somé, et al.
Published: (2022-08-01)

Efficacy of chloroquine, amodiaquine and sulphadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria: revisiting molecular markers in an area of emerging AQ and SP resistance in Mali
by: Wele Mamadou, et al.
Published: (2009-02-01)

Impact evaluation of malaria control interventions on morbidity and all-cause child mortality in Mali, 2000–2012
by: Kassoum Kayentao, et al.
Published: (2018-11-01)

Sub-national tailoring of seasonal malaria chemoprevention in Mali based on malaria surveillance and rainfall data
by: Mady Cissoko, et al.
Published: (2022-08-01)

A single full-length VAR2CSA ectodomain variant purifies broadly neutralizing antibodies against placental malaria isolates
by: Justin YA Doritchamou, et al.
Published: (2022-02-01)

Cost-effectiveness of district-wide seasonal malaria chemoprevention when implemented through routine malaria control programme in Kita, Mali using fixed point distribution
by: Halimatou Diawara, et al.
Published: (2021-03-01)

Use of a pLDH-based dipstick in the diagnostic and therapeutic follow-up of malaria patients in Mali
by: Ouattara Amed, et al.
Published: (2011-11-01)

Adapting malaria clinical trials infrastructure to implement COVID-19 epidemiology studies: Response to a public health emergency amid safe continuation of a research enterprise
by: John Woodford, et al.
Published: (2022-07-01)

Genetic polymorphisms with erythrocyte traits in malaria endemic areas of Mali.
by: Karim Traore, et al.
Published: (2019-01-01)

Risk management of adverse effects of antimalarial drugs: Knowledge of Physicians and Pharmacists in KAYES, MALI
by: Traore Boubacar, et al.
Published: (2021-01-01)

Seasonal vaccination against malaria: a potential use for an imperfect malaria vaccine
by: Brian Greenwood, et al.
Published: (2017-05-01)

“Spatial heterogeneity of environmental risk in randomized prevention trials: consequences and modeling”
by: Abdoulaye Guindo, et al.
Published: (2019-07-01)

Acceptability of the R21/Matrix-M malaria vaccine alongside existing malaria interventions in the trial context
by: Jayne Webster, et al.
Published: (2025-02-01)

Nutritional status in young children prior to the malaria transmission season in Burkina Faso and Mali, and its impact on the incidence of clinical malaria
by: Mariken de Wit, et al.
Published: (2021-06-01)

The anti-circumsporozoite antibody response to repeated, seasonal booster doses of the malaria vaccine RTS,S/AS01E
by: M. Sanni Ali, et al.
Published: (2025-02-01)

Malaria morbidity in children in the year after they had received intermittent preventive treatment of malaria in Mali: a randomized control trial.
by: Alassane Dicko, et al.
Published: (2011-01-01)

A randomized trial of dihydroartemisinin–piperaquine versus artemether–lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Mali
by: Souleymane Dama, et al.
Published: (2018-10-01)